Mar 17, 2022 / 01:00PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
So good morning, everybody. My name is Luke Sergott. I cover life science tools and diagnostics here at Barclays. It's my pleasure here to introduce Yair Malca, CFO of InMode. And I think he's going to kick off here with a little bit of video before the presentation. And then afterwards, we'll hold some Q&A. Go ahead.
Yair Malca - InMode Ltd. - CFO
Thank you very much, Luke, and thanks for having me. I'm the CFO of InMode. InMode is a leading provider of aesthetic medical device that's mainly focus on value frequency, and we'll touch about that in a bit later. But I think the best would be to start with a short video. Go ahead, run the video.
(presentation)
Yair Malca - InMode Ltd. - CFO
Excellent. I usually find this short video. Very -- it helps a lot of investors, especially that don't know the company or the procedures to visualize how some of the procedures look like. Now we'll move to my presentation.
So who we
Inmode Ltd at Barclays Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
